Physician
Clearview Diagnostic Imaging, LLC
Clearview Diagnostic Imaging, LLC was paid $172K by Medicaid between Jan 2018 and Oct 2024, across 10 billing codes. Its largest line is 78815, Positron emission tomography (PET) for limited area imaging — 73% of everything it billed.
33Billing provider infoCLEARVIEW DIAGNOSTIC IMAGING, LLC
HUNTSVILLE, AL 35805
HUNTSVILLE, AL 35805
33aNPI1164665931assigned 04/09/2009
33bProvider typeDiagnostic Radiology Physician
28Total paid$172K
24GClaims1,848
24DCodes billed10
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in Alabama
Rank by total paid#15 of 52
Median peer was paid$38K
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 285 | $20K | |
| 2019 | 65 | $9K | |
| 2020 | 68 | $22K | |
| 2021 | 319 | $30K | |
| 2022 | 86 | $12K | |
| 2023 | 443 | $63K | |
| 2024incomplete | 582 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78815 | Positron emission tomography (PET) for limited area imaging | 73% | 257 | 235 | $126K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 12% | 302 | 236 | $21K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 11% | 169 | 159 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 58 | 41 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.2% | 705 | 514 | $2K |
| 82565 | <1% | 42 | 27 | $60.00 | |
| G9321 | Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study | 0% | 65 | 49 | $0.00 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 32 | 32 | $0.00 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 182 | 152 | $0.00 |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 0% | 36 | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHREEDER, MARSHALL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Oncology Specialties, P.C. | Huntsville, AL | $1.94M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.